Vaxrevia DATA RELEASE - 2
By March 2021, MHRA had received 15,146 reports of cardiovascular events and 1,014 reports of thromboembolic events.
In our first post, we told the story of our quest for evidence of harms following vaccination with the Covid-19 AstraZeneca Vaccine (AZD1222/ChAdOx1-S), since christened Vaxrevia.
In this post, we ana…
